TripSitter Clinic Ltd.
TSTTF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $14 | $488 | $87 |
| % Growth | -100% | -97.1% | 459.8% | – |
| Cost of Goods Sold | $0 | $0 | $350 | $642 |
| Gross Profit | $0 | $14 | $139 | -$555 |
| % Margin | – | 100% | 28.4% | -635.9% |
| R&D Expenses | $0 | $3 | $286 | $286 |
| G&A Expenses | $0 | $353 | $1,330 | $2,089 |
| SG&A Expenses | $142 | $357 | $1,816 | $2,362 |
| Sales & Mktg Exp. | $0 | $4 | $487 | $273 |
| Other Operating Expenses | $0 | $2 | $246 | -$286 |
| Operating Expenses | $142 | $362 | $2,349 | $2,362 |
| Operating Income | -$142 | -$348 | -$1,852 | -$2,274 |
| % Margin | – | -2,493.6% | -379.3% | -2,607.5% |
| Other Income/Exp. Net | $132 | $44 | -$8 | $0 |
| Pre-Tax Income | -$10 | -$305 | -$1,869 | -$10,220 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$305 | -$1,869 | -$10,220 |
| % Margin | – | -2,181.5% | -382.7% | -11,717.4% |
| EPS | -0.001 | -0.005 | -0.031 | -0.43 |
| % Growth | 69.6% | 85.2% | 92.8% | – |
| EPS Diluted | -0.001 | -0.005 | -0.031 | -0.43 |
| Weighted Avg Shares Out | 6,658 | 66,582 | 60,582 | 60,582 |
| Weighted Avg Shares Out Dil | 6,658 | 66,582 | 60,582 | 60,582 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $15,891 |
| Depreciation & Amortization | $0 | $0 | $228 | $0 |
| EBITDA | -$10 | -$348 | -$1,852 | -$2,274 |
| % Margin | – | -2,493.6% | -379.3% | -2,607.5% |